Usefulness of desmopressin in reducing bleeding during insertion of tunneled dialysis catheters

Hemostatic effectiveness of intranasal desmopressin for tunneled dialysis catheter placement

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240215061017N2

Enrollment

Registered

2025-02-12

Start date

2025-02-25

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end stage renal disease. End stage renal disease

Interventions

Intervention 1: Intervention group: Patients in this group would be given a single puff of desmopressin in each nostril, 30 minutes before the insertion of tunneled dialysis catheters. After half an h

Eligibility

Sex/Gender

All

Age

12 Years to No maximum

Inclusion criteria

Inclusion criteria: End stage renal disease requiring insertion of tunneled dialysis catheter

Exclusion criteria

Exclusion criteria: Current use of anticoagulants Platelets count 180/110 mmHg Unwillingness

Design outcomes

Primary

Measure	Time frame
Bleeding from the catheter exit site. Timepoint: Within 24 hours of the intervention. Method of measurement: Visual inspection and reporting by the patients.	—

Secondary

Measure	Time frame
Need for intervention to control bleeding from catheter exit site. Timepoint: Within 24 hours of the interventon. Method of measurement: Review of medical records.;New onset headache (side effect). Timepoint: Within 24 hours of intervention. Method of measurement: Direct inquiry from the patient.	—

Countries

Pakistan

Contacts

Public ContactAbdul Rehman Arshad

CMH Lahore Medical College

maj.abdulrehman@gmail.com+92 335 6746747

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026